Get the Stockscreener App
7.11
0.56%
-0.04
After Hours:
7.11
Wave Life Sciences Ltd stock is traded at $7.11, with a volume of 2.27M.
It is down -0.56% in the last 24 hours and down -8.96% over the past month.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
See More
Previous Close:
$7.15
Open:
$7.14
24h Volume:
2.27M
Relative Volume:
0.87
Market Cap:
$1.20B
Revenue:
$93.95M
Net Income/Loss:
$-129.87M
P/E Ratio:
-7.90
EPS:
-0.9
Net Cash Flow:
$-202.88M
1W Performance:
-2.07%
1M Performance:
-8.96%
6M Performance:
+12.32%
1Y Performance:
-44.67%
1-Day Range:
$6.765
$7.21
1-Week Range:
$6.51
$7.3839
52-Week Range:
$5.28
$16.38
Wave Life Sciences Ltd Stock (WVE) Company Profile
Name
Wave Life Sciences Ltd
Sector
Industry
Phone
617-949-2900
Address
7 STRAITS VIEW, SINGAPORE
Compare WVE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
7.11 | 1.20B | 93.95M | -129.87M | -202.88M | -0.90 |
|
ARGX
Argen X Se Adr
|
918.53 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.52 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.92 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.34 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-04-25 | Initiated | Canaccord Genuity | Buy |
| Jul-28-25 | Initiated | Oppenheimer | Outperform |
| Jul-16-25 | Initiated | Citigroup | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-29-25 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-25 | Initiated | Wedbush | Outperform |
| Feb-25-25 | Initiated | Jefferies | Buy |
| Oct-16-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-27-24 | Resumed | JP Morgan | Overweight |
| Sep-19-24 | Initiated | B. Riley Securities | Buy |
| Sep-09-24 | Initiated | JP Morgan | Overweight |
| May-15-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-23 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jul-05-23 | Initiated | Raymond James | Outperform |
| May-24-23 | Downgrade | Jefferies | Buy → Hold |
| Dec-15-20 | Resumed | H.C. Wainwright | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-31-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-01-19 | Initiated | Guggenheim | Buy |
| Jul-15-19 | Initiated | Cowen | Market Perform |
| Apr-17-19 | Reiterated | H.C. Wainwright | Buy |
| Aug-07-18 | Initiated | Stifel | Buy |
| Jul-23-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Feb-15-17 | Initiated | H.C. Wainwright | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | JMP Securities | Mkt Outperform |
| Dec-07-15 | Initiated | Jefferies | Buy |
| Dec-07-15 | Initiated | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Wave Life Sciences Ltd Stock (WVE) Latest News
Why Wave Life Sciences Ltd. (1U5) stock gets analyst attention2025 Volatility Report & Safe Capital Preservation Plans - newser.com
Can Wave Life Sciences Ltd. (1U5) stock withstand sector downturnsJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
How reliable is Wave Life Sciences Ltd. (1U5) stock dividend growthEarnings Summary Report & Consistent Income Trade Recommendations - newser.com
What insider trading reveals about Wave Life Sciences Ltd. stockLayoff News & Accurate Intraday Trading Signals - newser.com
Why Wave Life Sciences Ltd. stock appeals to analystsWeekly Profit Report & Community Driven Trade Alerts - newser.com
Is Wave Life Sciences Ltd. meeting your algorithmic filter criteriaVolume Spike & Weekly Watchlist for Consistent Profits - newser.com
Wave Life Sciences Highlights RNA Platform Advancements - TipRanks
Wave Life Sciences Ltd Updates Corporate Presentation - TradingView
Can Wave Life Sciences Ltd. (1U5) stock hold up in economic slowdownCPI Data & AI Powered Buy and Sell Recommendations - newser.com
Jefferies Maintains "Buy" Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning - Finviz
Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning - Insider Monkey
Will Wave Life Sciences Ltd. (1U5) stock benefit from infrastructure bill2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com
Can Wave Life Sciences Ltd. rally from current levels2025 Market Trends & Low Drawdown Trading Techniques - newser.com
Can Wave Life Sciences Ltd. recover in the next quarterTrade Signal Summary & Safe Entry Zone Identification - newser.com
How Wave Life Sciences Ltd. stock compares to market leadersJuly 2025 Drop Watch & Accurate Buy Signal Alerts - newser.com
Heatmap analysis for Wave Life Sciences Ltd. and competitorsQuarterly Profit Review & Real-Time Buy Signal Notifications - newser.com
Ra Capital buys $6.7k in Wave Life Sciences (WVE) shares By Investing.com - Investing.com South Africa
10 Best Small-Cap Biotech Stocks to Buy According to Analysts - Insider Monkey
Ra Capital buys $6.7k in Wave Life Sciences (WVE) shares - Investing.com Nigeria
Insider Sell: Adrian Rawcliffe Sells Shares of WAVE Life Sciences Ltd (WVE) - GuruFocus
Wave Life Sciences director Rawcliffe sells $109k in stock By Investing.com - Investing.com South Africa
Wave Life Sciences director Rawcliffe sells $109k in stock - Investing.com India
Will Wave Life Sciences Ltd. (1U5) stock hit analyst forecastsBull Run & Daily Risk Controlled Trade Plans - newser.com
Can Wave Life Sciences Ltd. (1U5) stock expand revenue streams2025 Top Gainers & Precise Entry and Exit Recommendations - Fundação Cultural do Pará
Wave Life Sciences (WVE): Assessing Valuation After Recent Volatility and Analyst Price Target Gap - simplywall.st
Wave Life Sciences (WVE) Gains Edge as Rival's Drug Trials Falte - GuruFocus
WAVE Life Sciences Ltd (WVE) Q3 2025 Earnings Call Highlights: P - GuruFocus
WAVE Life Sciences Ltd (WVE) Q3 2025 Earnings Call Highlights: Promising Clinical Advances and ... - Yahoo Finance
Wave Life Sciences Hits Day Low of $6.72 Amid Price Pressure - Markets Mojo
Can Wave Life Sciences (WVE) Sustain Innovation With Its Extended Cash Runway and Clinical Progress? - Yahoo Finance
Visual analytics tools that track Wave Life Sciences Ltd. performanceInflation Watch & Low Risk High Win Rate Picks - newser.com
Could Wave Life Sciences' (WVE) Novel Obesity Data Reveal a Strategic Shift in Its Pipeline Focus? - simplywall.st
Is Wave Life Sciences Ltd. stock entering bullish territory2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
Wells Fargo Maintains Wave Life Sciences (WVE) Overweight Recommendation - Nasdaq
Wave Life Sciences Ltd Stock (WVE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.08%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):